Home/Filings/4/0001140361-25-006082
4//SEC Filing

Flynn Sean C. 4

Accession 0001140361-25-006082

CIK 0000887359other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 4:05 PM ET

Size

10.5 KB

Accession

0001140361-25-006082

Insider Transaction Report

Form 4
Period: 2025-02-24
Flynn Sean C.
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-24+3,0009,000 total
    Common Stock (3,000 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-24+3,0003,756 total
  • Tax Payment

    Common Stock

    2025-02-24$52.33/sh1,331$69,6512,425 total
  • Sale

    Common Stock

    2025-02-25$52.07/sh1,669$86,905756 total
Footnotes (7)
  • [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively.
  • [F2]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F3]These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
  • [F4]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.
  • [F5]Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
  • [F6]No expiration date for this type of award.
  • [F7]The Fair Market Value of the vested derivative securities is $52.33 per share.

Issuer

Vericel Corp

CIK 0000887359

Entity typeother

Related Parties

1
  • filerCIK 0001801993

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 4:05 PM ET
Size
10.5 KB